Decreased anti‐Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn’s disease

Saccharomyces cerevisiae may contribute to the pathophysiology of Crohn’s disease. We determined serum anti‐Saccharomyces cerevisiae antibody (ASCA) levels in patients with inflammatory bowel disease.

[1]  S. Targan,et al.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.

[2]  S. Targan,et al.  Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. , 1998, Gastroenterology.

[3]  P. Jacquinot,et al.  Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.

[4]  A. Tarkowski,et al.  Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis. , 1995, Annals of the rheumatic diseases.

[5]  A. Sonnenberg,et al.  Lymphocyte proliferation response to baker's yeast in Crohn's disease. , 1994, Digestion.

[6]  C. Holdsworth,et al.  Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. , 1992, Gut.

[7]  E. Lindberg,et al.  Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. , 1992, Gut.

[8]  J. Main,et al.  Antigenic heterogeneity of strains of Saccharomyces cerevisiae and Candida albicans recognised by serum antibodies from patients with Crohn's disease. , 1992, FEMS microbiology immunology.

[9]  C. Pennington,et al.  The effect of dietary yeast on the activity of stable chronic Crohn's disease. , 1992, Scandinavian journal of gastroenterology.

[10]  T. Suzuki,et al.  Effect of sulfasalazine on B cells. , 1991, Clinical and experimental rheumatology.

[11]  A. Sonnenberg.  Occupational distribution of inflammatory bowel disease among German employees. , 1990, Gut.

[12]  A. Sonnenberg.  Occupational mortality of inflammatory bowel disease. , 1990, Digestion.

[13]  S. Allan,et al.  Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease? , 1990, International archives of allergy and applied immunology.

[14]  M. Kerr,et al.  Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.

[15]  Jasin He,et al.  In vitro immunomodulatory effects of sulfasalazine and its metabolites. , 1988 .

[16]  P. Knoflach,et al.  Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease. , 1987, Gastroenterology.

[17]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[18]  G. Settipane,et al.  Corticosteroid effect on immunoglobulins. , 1978, The Journal of allergy and clinical immunology.

[19]  R. Mcmillan,et al.  The effect of corticosteroids on human IgG synthesis. , 1976, Journal of immunology.

[20]  T. D. McCaffery,et al.  The influence of different techniques in characterizing human antibodies to cow's milk proteins. , 1972, Clinical and experimental immunology.

[21]  K. Taylor,et al.  Circulating Antibodies to Milk Proteins in Ulcerative Colitis , 1961, British medical journal.